Orexo publishes prospectus and applies for admission to trading of social bonds on Nasdaq Stockholm

Rhea-AI Summary

Orexo AB (ORXOY) has successfully issued senior secured callable floating rate social bonds worth SEK 500 million with a tenor of four years. The company has applied for admission to trading of the bonds on Nasdaq Stockholm after having the listing prospectus approved by the Swedish Financial Supervisory Authority. The estimated first day of trading is around May 14, 2024.

UPPSALA, Sweden, May 10, 2024 /PRNewswire/ -- On March 28, 2024, Orexo AB (publ), ("Orexo" or the "Company") (STO: ORX) (OTCQX: ORXOY) successfully issued senior secured callable floating rate social bonds in an amount of SEK 500 million and with a tenor of four years (the "Bonds").

Pursuant to the terms and conditions for the Bonds, Orexo has undertaken to apply for admission to trading of the Bonds on the sustainable bond list of Nasdaq Stockholm. For this purpose, the Company has prepared a listing prospectus, which today has been approved by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen). The prospectus is available at the Company's website www.orexo.com and at the Swedish Financial Supervisory Authority's website www.fi.se. The application for admission to trading has been submitted and the first day of trading of the Bonds is estimated to be around May 14, 2024.

For further information please contact:
Nikolaj Sørensen, President and CEO
Fredrik Järrsten, EVP and CFO
Lena Wange, IR & Communications Director
Tel: +46 (0)18 780 88 00
E-mail: ir@orexo.com

About Orexo
Orexo is a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs. On the US market, Orexo provides innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with leading partners. Total net sales in 2023 amounted to SEK 639 million, and the number of employees to 116. Orexo is listed on Nasdaq Stockholm's main list and is available as an ADR on OTCQX (ORXOY) in the US.

For more information about Orexo please visit www.orexo.com. You can also follow Orexo on X, LinkedIn, and YouTube.

The information was sent for publication, through the agency of the contact person set out above, on May 10, 2024, at 1.30 pm CET.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/orexo/r/orexo-publishes-prospectus-and-applies-for-admission-to-trading-of-social-bonds-on-nasdaq-stockholm,c3976889

The following files are available for download:

https://mb.cision.com/Main/694/3976889/2788792.pdf

Orexo publishes prospectus and applies for admission to trading of social bonds on Nasdaq Stockholm

 

View original content:https://www.prnewswire.com/news-releases/orexo-publishes-prospectus-and-applies-for-admission-to-trading-of-social-bonds-on-nasdaq-stockholm-302142294.html

SOURCE Orexo

FAQ

When did Orexo issue the social bonds?

Orexo issued the social bonds on March 28, 2024.

What is the amount of the social bonds issued by Orexo?

Orexo issued senior secured callable floating rate social bonds worth SEK 500 million.

Where has Orexo applied for admission to trading of the bonds?

Orexo has applied for admission to trading of the bonds on the sustainable bond list of Nasdaq Stockholm.

When is the estimated first day of trading of the bonds?

The estimated first day of trading of the bonds is around May 14, 2024.